The U.S. district attorney for Massachusetts filed suit against the drugmaker this week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.
The company has signed an initial partnership with Genentech that will focus on understanding the genetic components that are related to a person's risk of developing ocular diseases like macular degeneration.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company's technology for screening diabetic retinopathy was granted "Breakthrough Device" designation and is able to provide a clinical decision, instead of simply a recommendation to the physician.
The analysis said that the consent forms signed by the women did not mention a clinical trial.
Clearside Biomedical will use the Series C round to further clinical trials for its drug-device combination for diseases of the eye that cause blindness.
One of the most commonly prescribed drugs for wet age-related macular degeneration is Avastin – a cancer drug. So it’s not that surprising that a new approach for wet AMD is radiation therapy – with aims to halt the growth of the unruly blood vessels that cause the disease. Arizona startup Salutaris Medical Devices is developing a device […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Researchers have been exploring the potential of laser light therapy in a number of disease states for quite a while. Poulsbo, Washington startup LumiThera is developing an LED light-based instrument, for use in an ophthalmologist’s office, to treat the dry form of acute macular degeneration. The company uses low-level light therapy, or LLLT, in which patients are […]
Rather than using injections to deliver treatments to the middle and back of the eye, Kala Pharmaceuticals might have a way to get them there with topical drops. The Massachusetts-based company is developing eye drops designed to carry drugs through the layer of mucus on the eye’s surface — a barrier that typically gets in […]
With an aging population and rising rates of vision loss, the U.S. pharmaceutical and medical device industries have latched onto ophthalmology as an area where innovation is both needed and lucrative. Cleveland-area startup Visum Therapeutics is one of the companies going after an orphan eye disease called Stargardt disease, which is a juvenile manifestation of […]
A cure for spinal cord injury? Diabetes? Macular degeneration? Hope or just hype? There are now some clinical trials using embryonic stem cells to treat serious diseases for which no other good therapy is currently available. But this is just the beginning of a major medical megatrend that will blossom forth in the coming years. […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.